Medpage Today: Offer STI screening to every adolescent who visits the ED
UC physician suggests screening teens who visit emergency rooms for sexually transmitted infections
Mark Eckman, MD, professor and director of the UC Division of General Internal Medicine, conducted a computer analysis that simulated outcomes for screening pediatric emergency room patients ages 15-21 for sexually transmitted infections. It will add costs to hospital budgets but Eckman says it also helps combat future health complications of STIs for young people.
Eckman, also a UC Health physician, used a hypothetical population that included 10,000 emergency room visits Eckman looked at a 3.6% prevalence of chlamydia and gonorrhea - the same amount generally found in the nation's young adult population - and the impact of targeted screening, universal screening and no screening. Under the scenario 360 STI cases would be present.
Targeted screening resulted in the detection and successful treatment of 95 of 360 STI cases (26.4%) at a cost of $313,063 and universally offered screening identified and treated 112 of 360 STI cases (31.1%) at a cost of $515,503. If no screening were done, testing only patients who present with complaints or concerns about STIs, 76 of 360 cases (21.1%) would be found at a cost of $190,409.
The study’s results in its entirety were recently published in the Journal of American Medical Association Pediatrics and reported by MedPage Today.
“Untreated chlamydia or gonorrhea can in women lead to pelvic inflammatory disease and ectopic pregnancies because of scarring in the fallopian tubes, while men can face epididymitis,” explains Eckman. “Women and men could face infertility if these sexually transmitted infections are not treated.”
Nationally, adolescents and young adults represent 25% of the sexually active population, but comprise 50% of all diagnosed sexually transmitted infection cases. Of the 20 million new cases of sexually transmitted cases each year 10 million occur among adolescents and young adults.
Collaborators on this work include Jennifer L. Reed, Cincinnati Children’s Hospital Medical Center; Maria Trent, Johns Hopkins Medical Center; and Monika Goyal, Children’s National Hospital, the George Washington University, in conjunction with the Pediatric Emergency Care Applied Research Network.
Read Medpage Today’s full story on Dr. Eckman’s research online.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.